{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:04:10Z","timestamp":1790622250847,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejim.2011.09.016","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T08:39:40Z","timestamp":1319791180000},"page":"6-8","source":"Crossref","is-referenced-by-count":36,"title":["Developing strategies to improve the quality of life of patients with gluten intolerance in patients with and without coeliac disease"],"prefix":"10.1016","volume":"23","author":[{"given":"D.","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.09.016_bb0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/003655200750023967","article-title":"Prevalence of coeliac disease in the general population of northern Spain. Strategies of serologic screening","volume":"35","author":"Riestra","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0010","first-page":"234","article-title":"Epidemiology of coeliac disease","volume":"66","author":"Schapira","year":"2003","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.ejim.2011.09.016_bb0015","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.52.7.960","article-title":"Seroprevalence, correlates, and characteristics of undetected coeliac disease in England","volume":"52","author":"West","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(94)90989-X","article-title":"Coeliac disease in the year 2000: exploring the iceberg","volume":"343","author":"Catassi","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.09.016_bb0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nri885","article-title":"Coeliac disease: dissecting a complex inflammatory disorder","volume":"2","author":"Sollid","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-immunol-040210-092915","article-title":"Integration of genetic and immunological insights into a model of celiac disease pathogenesis","volume":"29","author":"Abadie","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0035","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","article-title":"Celiac disease","volume":"357","author":"Green","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.09.016_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.gtc.2008.02.001","article-title":"Celiac disease and autoimmunity in the gut and elsewhere","volume":"37","author":"Barton","year":"2008","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ejim.2011.09.016_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1474-4422(09)70290-X","article-title":"Gluten sensitivity: from gut to brain","volume":"9","author":"Hadjivassiliou","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1528-1167.2011.03030.x","article-title":"Systemic and neurologic autoimmune disorders associated with seizures or epilepsy","volume":"52","author":"Vincent","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejim.2011.09.016_bb0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejim.2010.01.015","article-title":"Current methods to diagnose the unresponsive and complicated forms of coeliac disease","volume":"21","author":"Hadithi","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2011.09.016_bb0065","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ajg.2011.104","article-title":"The incidence and clinical spectrum of refractory celiac disease in a North American referral center","volume":"106","author":"Roshan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0080","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2036.2009.03992.x","article-title":"Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet","volume":"29","author":"Lanzini","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.09.016_bb0085","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.4049\/jimmunol.0803181","article-title":"Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease","volume":"182","author":"Camarca","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/gut.2010.225268","article-title":"Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease","volume":"60","author":"Comino","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imlet.2006.03.004","article-title":"The changing immunological paradigm in coeliac disease","volume":"105","author":"Brandtzaeg","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ejim.2011.09.016_bb0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncpgasthep0582","article-title":"Mechanisms of disease: immunopathogenesis of celiac disease","volume":"3","author":"Jabri","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.molimm.2004.12.005","article-title":"Gliadin as a stimulator of innate responses in celiac disease","volume":"42","author":"Londei","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","article-title":"Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease","volume":"362","author":"Maiuri","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.09.016_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(03)01049-7","article-title":"Alterations of the intestinal transport and processing of gliadin peptides in celiac disease","volume":"125","author":"Matysiak-Budnik","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.52.2.218","article-title":"Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function","volume":"52","author":"Clemente","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/gast.2000.18149","article-title":"Interleukin 15 mediates epithelial changes in celiac disease","volume":"119","author":"Maiuri","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ejim.2011.09.016_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ejim.2011.09.016_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2567.2005.02132.x","article-title":"IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity","volume":"115","author":"Ebert","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2249.2008.03743.x","article-title":"Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients","volume":"154","author":"Bernardo","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.gastro.2006.06.002","article-title":"A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells","volume":"131","author":"Raki","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0160","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4049\/jimmunol.173.3.1757","article-title":"Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion","volume":"173","author":"Qiao","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0165","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1172\/JCI27620","article-title":"HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease","volume":"116","author":"Tollefsen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2011.09.016_bb0170","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/gut.37.6.766","article-title":"Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma","volume":"37","author":"Nilsen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0175","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.febslet.2005.07.066","article-title":"Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins","volume":"579","author":"Sander","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejim.2011.09.016_bb0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00365520500235334","article-title":"Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines","volume":"41","author":"Drago","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0185","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.3748\/wjg.v11.i38.5973","article-title":"Damaging effects of gliadin on three-dimensional cell culture model","volume":"11","author":"Dolfini","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/gut.2006.118265","article-title":"Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides","volume":"56","author":"Bernardo","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.09.016_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.febslet.2004.06.057","article-title":"Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB","volume":"571","author":"Jelinkova","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejim.2011.09.016_bb0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10875-006-9061-z","article-title":"Gliadin peptides activate blood monocytes from patients with celiac disease","volume":"27","author":"Cinova","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0887-2333(02)00017-6","article-title":"In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line","volume":"16","author":"Dolfini","year":"2002","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ejim.2011.09.016_bb0210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0887-2333(96)00042-2","article-title":"Inhibition of the cellular metabolism of Caco-2 cells by prolamin peptides from cereals toxic for coeliacs","volume":"10","author":"Giovannini","year":"1996","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ejim.2011.09.016_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(03)00236-9","article-title":"Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway","volume":"540","author":"Giovannini","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejim.2011.09.016_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0300-483X(99)00223-1","article-title":"Induction of apoptosis in caco-2 cells by wheat gliadin peptides","volume":"145","author":"Giovannini","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.ejim.2011.09.016_bb0225","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ajg.2010.487","article-title":"Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial","volume":"106","author":"Biesiekierski","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.09.016_bb0230","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-277X.2010.01139.x","article-title":"Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals","volume":"24","author":"Biesiekierski","year":"2011","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.ejim.2011.09.016_bb0235","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2796.2011.02376.x","article-title":"Novel therapies for coeliac disease","volume":"269","author":"Sollid","year":"2011","journal-title":"J Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T03:59:20Z","timestamp":1543463960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511002317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0953620511002317"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.09.016","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}